CHANNELS

Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  CORE Diagnostics Appoints New CEO to Accelerate Growth

[June 24, 2014]

CORE Diagnostics Appoints New CEO to Accelerate Growth

PALO ALTO, Calif. --(Business Wire)--

CORE Diagnostics, Inc., the leading high-end clinical diagnostics laboratory, announced today the appointment of K. Balachandran (Bala) as chief executive officer, effective immediately.

With more than 25 years of experience with large publicly traded companies both domestically and internationally, Bala brings to CORE hands-on knowledge of the healthcare industry and the high-tech sector. Most recently, Bala served as the chief operating officer of NeuroMetrix, Inc., where he successfully transitioned the company's strategic direction to point-of-care diabetic neuropathy and put the company on a growth trajectory. Previously, after 8 years with HP in various program management and P&L roles based in California, including director of the company's strategic alliances, he joined Cardinal Health as vice president and general manager of the NeuroCare business division and oversaw a global P&L of $150 million. Pior to that, Bala was a leader at Nicolet Biomedical in Madison, Wis., as the director for the Asia Pacific business and advanced to become vice president of Nicolet's international business.

"Bala's intimate knowledge of the healthcare industry, customer focus and P&L experience coupled with his track record in developing international markets are an excellent fit with our needs," said Dr. Ajit Singh, managing director and general partner at Artiman Ventures, and chairman of the board of CORE Diagnostics. "We are very pleased to have him on board and look forward to his contributions as we continue developing CORE Diagnostics into a premier clinical pathology laboratory and contract research organization."

CORE Diagnostics is focused on bringing the most advanced testing techniques and expertise to routine clinical practice. The company offers a rich menu of high-end tests and provides patients with peace of mind by delivering second opinions on every test from at least two specialists from its global panel of pathologists.

"It is a great privilege to lead the extremely talented people at CORE Diagnostics at such a time when the company is positioned for growth, both in its clinical pathology biopharma research initiatives globally," said K. Balachandran, CEO at CORE Diagnostics.

ABOUT CORE DIAGNOSTICS

CORE Diagnostics is a clinical laboratory offering next generation diagnostics for disease stratification and therapy selection. With offices in Palo Alto, CA (News - Alert), and Gurgaon, India, CORE Diagnostics offers a comprehensive menu of specialized, advanced diagnostic testing in the areas of cardiology, oncology, reproductive disorders, endocrinology and infectious diseases. The company also deploys next generation sequencing in clinical applications and uses digital pathology for enabling concurrent global review of test results. CORE Diagnostics is backed by Artiman Ventures, the leading white space investment firm based in Palo Alto, Calif. For more information, please visit www.corediagnostics.in.


[ InfoTech Spotlight's Homepage ]


blog comments powered by Disqus

FOLLOW US

Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter